Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...

DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...

January would have marked the 53rd anniversary of Roe v. Wade, the 1973 Supreme Court decision that legalized abortion ...

(RNS) — The movement got what it wanted. Abortions increased anyway.

At a Glance The FDA reversed its 2022 NMN ban in September 2025, allowing the $500 million ingredient back on the market ...

In 2025, the U.S. Food and Drug Administration (“FDA”) and U.S. Department of Justice (“DOJ”) pursued significant criminal, ...

Lousiana AG Liz Murrill is hopeful a judge will reject the Trump administration's request to pause her abortion pill lawsuit.

A small crowd gathers on Natchez Bluff for the annual Miss-Lou Right to Life Rally, blending worship and prayer while voicing ...

Murrill wants the agency to reverse regulatory action it took in 2023 in response to the COVID-19 pandemic, when patient ...

State law still allows tobacco sales at 18, despite a federal ban on sales under 21.

Deals: Boehringer Ingelheim agreed to a pact with Simcere Pharmaceutical that could be worth approximately $1.26 billion. Eli Lilly announced it will work with startup Seamless Th ...